Agios Pretax Profit Margin from 2010 to 2024

AGIO Stock  USD 29.12  0.06  0.21%   
Agios Pharm Pretax Profit Margin yearly trend continues to be very stable with very little volatility. Pretax Profit Margin is likely to grow to -12.47 this year. During the period from 2010 to 2024, Agios Pharm Pretax Profit Margin quarterly data regression pattern had range of 15.5226 and standard deviation of  5.90. View All Fundamentals
 
Pretax Profit Margin  
First Reported
2010-12-31
Previous Quarter
(13.13)
Current Value
(12.47)
Quarterly Volatility
5.9035641
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Agios Pharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agios main balance sheet or income statement drivers, such as Depreciation And Amortization of 7 M, Interest Expense of 15.4 M or Selling General Administrative of 81.2 M, as well as many exotic indicators such as Price To Sales Ratio of 32.17, Dividend Yield of 0.015 or Operating Cycle of 1.1 K. Agios financial statements analysis is a perfect complement when working with Agios Pharm Valuation or Volatility modules.
  
This module can also supplement Agios Pharm's financial leverage analysis and stock options assessment as well as various Agios Pharm Technical models . Check out the analysis of Agios Pharm Correlation against competitors.
To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.

Latest Agios Pharm's Pretax Profit Margin Growth Pattern

Below is the plot of the Pretax Profit Margin of Agios Pharm over the last few years. It is Agios Pharm's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agios Pharm's overall financial position and show how it may be relating to other accounts over time.
Pretax Profit Margin10 Years Trend
Slightly volatile
   Pretax Profit Margin   
       Timeline  

Agios Pretax Profit Margin Regression Statistics

Arithmetic Mean(5.59)
Coefficient Of Variation(105.63)
Mean Deviation5.00
Median(2.84)
Standard Deviation5.90
Sample Variance34.85
Range15.5226
R-Value(0.81)
Mean Square Error13.09
R-Squared0.65
Significance0.0003
Slope(1.07)
Total Sum of Squares487.93

Agios Pretax Profit Margin History

2024 -12.47
2023 -13.13
2021 -16.28
2020 -1.61
2019 -3.49
2018 -3.67
2017 -7.32

About Agios Pharm Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Agios Pharm income statement, its balance sheet, and the statement of cash flows. Agios Pharm investors use historical funamental indicators, such as Agios Pharm's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although Agios Pharm investors may use each financial statement separately, they are all related. The changes in Agios Pharm's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Agios Pharm's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Agios Pharm Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Agios Pharm. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Pretax Profit Margin(13.13)(12.47)

Agios Pharm Investors Sentiment

The influence of Agios Pharm's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Agios. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Agios Pharm's public news can be used to forecast risks associated with an investment in Agios. The trend in average sentiment can be used to explain how an investor holding Agios can time the market purely based on public headlines and social activities around Agios Pharm. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Agios Pharm's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Agios Pharm's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Agios Pharm's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Agios Pharm.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Agios Pharm in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Agios Pharm's short interest history, or implied volatility extrapolated from Agios Pharm options trading.

Pair Trading with Agios Pharm

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agios Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will appreciate offsetting losses from the drop in the long position's value.

Moving together with Agios Stock

  0.89EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Agios Stock

  0.84TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.78KA Kineta Inc Report 29th of March 2024 PairCorr
  0.74VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.69MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.64DBVT DBV Technologies Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Agios Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agios Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agios Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agios Pharm to buy it.
The correlation of Agios Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agios Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agios Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agios Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Agios Pharm offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agios Pharm's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agios Pharm Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agios Pharm Stock:
Check out the analysis of Agios Pharm Correlation against competitors.
To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Agios Stock analysis

When running Agios Pharm's price analysis, check to measure Agios Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agios Pharm is operating at the current time. Most of Agios Pharm's value examination focuses on studying past and present price action to predict the probability of Agios Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agios Pharm's price. Additionally, you may evaluate how the addition of Agios Pharm to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Agios Pharm's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.33)
Revenue Per Share
0.482
Quarterly Revenue Growth
0.648
Return On Assets
(0.22)
Return On Equity
(0.37)
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.